共 30 条
[1]
Lewington S., Whitlock G., Clarke R., Sherliker P., Emberson J., Et al., Blood cholesterol and vascular mortality by age, sex, and blood pressure: A meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths, Lancet, 370, pp. 1829-1839, (2007)
[2]
Lopez-Jimenez F., Batsis J.A., Roger V.L., Brekke L., Ting H.H., Somers V.K., Trends in 10-year predicted risk of cardiovascular disease in the United States, 1976 to 2004, Circ Cardiovasc Qual Outcomes, 2, pp. 443-450, (2009)
[3]
Craig R., Mindell J., Hirani V., Health Survey for England 2008, (2009)
[4]
Baigent C., Keech A., Kearney P.M., Blackwell L., Buck G., Pollicino C., Et al., Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins, Lancet, 366, pp. 1267-1278, (2005)
[5]
Law M.R., Morris J.K., Wald N.J., Use of blood pressure lowering drugs in the prevention of cardiovascular disease: Meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies, BMJ, 338, (2009)
[6]
Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D., Lifetime risk of developing coronary heart disease, Lancet, 353, 9147, pp. 89-92, (1999)
[7]
Ridker P.M., Statin therapy for low-LDL, high-hsCRP patients: From JUPITER to CORONA, Clin Chem, 56, pp. 505-507, (2010)
[8]
Moon J.C., Bogle R.G., Switching statins, BMJ, 332, pp. 1344-1345, (2006)
[9]
Rose G., Strategy of prevention: Lessons from cardiovascular disease, British Medical Journal, 282, 6279, pp. 1847-1851, (1981)
[10]
Wald N.J., Hackshaw A.K., Frost C.D., When can a risk factor be used as a worthwhile screening test?, BMJ, 319, pp. 1562-1565, (1999)